ArticleHuman vaccines & immunotherapeutics2016
Awareness and acceptance of human papillomavirus (HPV) vaccination among males attending a major sexual health clinic in Wuxi, China: A cross-sectional study.
Article in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.
- Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature.European journal of cancer care · 2022Pooled it
- Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies.BMC public health · 2016Pooled it
- Application of an extended information-motivation-behavioral skills model to predict HPV vaccine acceptability among Chinese gay, bisexual, and other men who have sex with men.Human vaccines & immunotherapeutics · 2026Article
- A WeChat-delivered Information-Motivation-Behavioral skills intervention to improve HPV vaccine acceptability among Chinese gay, bisexual, and other men who have sex with men.Human vaccines & immunotherapeutics · 2026Article
- Predictors of parental acceptance to live attenuated influenza vaccine for children.Human vaccines & immunotherapeutics · 2024Article
- Review
- Factors influencing HPV vaccination willingness among men who have sex with men in China: a structural equation modeling analysis.Human vaccines & immunotherapeutics · 2022Article
- Awareness and acceptance of HPV vaccination for condyloma acuminata among men who have sex with men in China.Human vaccines & immunotherapeutics · 2022Article
- Characterizing Wuhan residents' mask-wearing intention at early stages of the COVID-19 pandemic.Patient education and counseling · 2021Article
- Heat maps present the spatial distribution of human papillomavirus infection in Zhejiang Province, China.Oncology letters · 2021Article
- Improving the Acceptability of Human Papillomavirus Vaccines Among Men Who Have Sex With Men According to the Associated Factors: A Systematic Review and Meta-analysis.Frontiers in pharmacology · 2021Article
- Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China.Journal of general internal medicine · 2019Article
- Parental perceptions of human papillomavirus vaccination in central China: the moderating role of socioeconomic factors.Human vaccines & immunotherapeutics · 2019Article
- HPV vaccination acceptability among men who have sex with men in Urumqi, China.Human vaccines & immunotherapeutics · 2019Article
- Knowledge, understanding, attitude, perception and views on HPV infection and vaccination among health care students and professionals in Malaysia.Human vaccines & immunotherapeutics · 2019Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 6 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo study the awareness and acceptance of human papillomavirus (HPV) vaccination among sexually active men having sex with men (MSM) and men not having sex with men (MNSM) attending the largest sexual health clinic in Wuxi, China.
methodsA questionnaire about participants' socio-demographic characteristics and view on HPV vaccination was collected.
resultsA total of 186 MSM and 182 MNSM were recruited. Among MSM, 12.4% were under 20 years old, 64.5% never married and 56.5% from Jiangsu Province (where Wuxi City is located); 64.0% had resided in Wuxi for over 2 years, 64.5% had high school education or more, and 83.9% had an income of 5000 RMB or less per month compared to figures of 5.5%, 50.6%, 73.6%, 54.9%, 86.8% and 64.8% among MNSM, respectively (All P values < 0.05). Among these 2 groups of men, 18.4% and 23.1% had heard of HPV; 10.2% and 15.4% had heard of HPV vaccine; and 26.2% and 20.2% would take HPV vaccine before sexual debut, respectively. MNSM were significantly more willing to take HPV vaccine than MSM (70.9 vs 34.9%, p < 0.001). Factors associated with HPV vaccine acceptance among MSM included engaging mostly in receptive anal sex (Odds ratio (OR)=3.9, 95% Confidence interval (CI): 1.8-13.5), never using a condom in anal sex in the past 6 months (3.5, 1.5-20.2), ever diagnosed with a sexually transmitted infection (STI) (3.4, 1.3-8.4) and ever receiving HIV related services (1.6, 1.1-4.4). Among MNSM these Factors included commercial sex with women (1.7, 1.2-8.6), never using a condom in commercial sex (1.6, 1.4-7.6) and STI diagnosis (2.0, 1.6-7.3).
conclusionsSexually active MSM and MNSM in Wuxi lacked knowledge of HPV and HPV vaccination. The majority of these at-risk men would not benefit from HPV vaccination as their age at first sex proceeded perceived age of vaccine uptake. Aggressive education aimed at increasing knowledge of HPV and HPV vaccination among these men is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.